Detalhe da pesquisa
1.
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.
Mod Pathol
; 35(12): 1888-1899, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36115922
2.
Programmed death-ligand 1 expression influenced by tissue sample size. Scoring based on tissue microarrays' and cross-validation with resections, in patients with, stage I-III, non-small cell lung carcinoma of the European Thoracic Oncology Platform Lungscape cohort.
Mod Pathol
; 33(5): 792-801, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31740722
3.
Correction to: Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.
Mod Pathol
; 35(12): 2033, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36253399
4.
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
Lancet
; 386(9998): 1049-56, 2015 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26275735
5.
Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Lancet Oncol
; 16(16): 1651-8, 2015 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-26538423
6.
GAS5 long non-coding RNA in malignant pleural mesothelioma.
Mol Cancer
; 13: 119, 2014 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-24885398
7.
Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial.
Lung Cancer
; 175: 141-151, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36535121
8.
PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma.
J Immunother Cancer
; 11(10)2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37880184
9.
European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database.
J Thorac Oncol
; 18(9): 1233-1247, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37356802
10.
Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin.
BMC Cancer
; 12: 571, 2012 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23211021
11.
Prognostic impact of tumour mutational burden in resected stage I and II lung adenocarcinomas from a European Thoracic Oncology Platform Lungscape cohort.
Lung Cancer
; 174: 27-35, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36283211
12.
Extended resection for potentially operable patients with stage III non-small cell lung cancer after induction treatment.
J Thorac Cardiovasc Surg
; 164(6): 1587-1602.e5, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35688713
13.
A prognostic score for patients with malignant pleural mesothelioma (MPM) receiving second-line immunotherapy or chemotherapy in the ETOP 9-15 PROMISE-meso phase III trial.
Lung Cancer
; 169: 77-83, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35660972
14.
Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim.
Ann Hematol
; 90(1): 89-94, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20706722
15.
Prognostic Impact of KRAS G12C Mutation in Patients With NSCLC: Results From the European Thoracic Oncology Platform Lungscape Project.
J Thorac Oncol
; 16(6): 990-1002, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33647504
16.
Combined, patient-level, analysis of two randomised trials evaluating the addition of denosumab to standard first-line chemotherapy in advanced NSCLC - The ETOP/EORTC SPLENDOUR and AMGEN-249 trials.
Lung Cancer
; 161: 76-85, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34543941
17.
Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14).
J Thorac Oncol
; 16(2): 278-288, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33188912
18.
Equivalence of pegfilgrastim and filgrastim in lymphoma patients treated with BEAM followed by autologous stem cell transplantation.
Oncology
; 79(1-2): 93-7, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21079406
19.
Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial.
Lancet Oncol
; 10(8): 785-93, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19604722
20.
Intracavitary cisplatin-fibrin chemotherapy after surgery for malignant pleural mesothelioma: A phase I trial.
J Thorac Cardiovasc Surg
; 159(1): 330-340.e4, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31590949